Patents by Inventor Thomas Ammann

Thomas Ammann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200375640
    Abstract: A wrist arthrodesis plate (20) consisting of a distal region (21) and of a proximal region (22) which adjoins the distal region (21) in the direction of a longitudinal axis (A). The plate (20) is of such a shape and size that the distal region (21) of the plate can be fastened to the carpus (1) and a proximal region (22) of the plate can be fastened to the radius (3) by fastening devices, such as screws, which can be inserted into plate holes. A distal end region (29), which comprises a farthest distal location (23) of the plate (20), is of a shape and size that the distal end region (29) can be placed with the farthest distal location (23) exactly, and only, on a carpal bone from the group comprising trapezium (11), trapezoid (10), capitate (9) and hamate (8), without covering any part of the laterally adjacent bones.
    Type: Application
    Filed: February 6, 2019
    Publication date: December 3, 2020
    Inventors: Daniel EBI, Radek KEBRLE, Marc AMMANN, Daniel KAINZ, Simon Martin SCHĂ„TZLE, Thomas TRIBELHORN
  • Publication number: 20200368236
    Abstract: The present invention is directed to stable lyophilisates comprising 5,10-methylene-(6R)-tetrahydrofolic acid or a pharmaceutically acceptable salt thereof and a dicarboxylic acid, or a salt thereof, as well as, a processes of obtaining the same, and the use of such products.
    Type: Application
    Filed: August 15, 2018
    Publication date: November 26, 2020
    Applicant: Merck Patent GmbH
    Inventors: Rudolf MOSER, Viola GROEHN, Thomas AMMANN
  • Publication number: 20200283443
    Abstract: The invention is directed towards stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid and its hemisulfate salt as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.
    Type: Application
    Filed: February 20, 2020
    Publication date: September 10, 2020
    Applicant: MERCK & CIE
    Inventors: Rudolf MOSER, Viola GROEHN, Thomas EGGER, Thomas AMMANN
  • Patent number: 10570134
    Abstract: The invention is directed towards stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid and its hemisulfate salt as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: February 25, 2020
    Assignee: MERCK & CIE
    Inventors: Rudolf Moser, Viola Groehn, Thomas Egger, Thomas Ammann
  • Publication number: 20190270745
    Abstract: The invention is directed towards stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid and its hemisulfate salt as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.
    Type: Application
    Filed: May 17, 2019
    Publication date: September 5, 2019
    Applicant: MERCK & CIE
    Inventors: Rudolf MOSER, Viola GROEHN, Thomas EGGER, Thomas AMMANN
  • Patent number: 10336758
    Abstract: The invention is directed towards stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid and its hemisulfate salt as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: July 2, 2019
    Assignee: MERCK & CIE
    Inventors: Rudolf Moser, Viola Groehn, Thomas Egger, Thomas Ammann
  • Publication number: 20190106431
    Abstract: The present invention is directed towards the hemisulfate salt of 5,10-methylene-(6R)-tetrahydrofolic acid, preferably in substantially crystalline form, as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.
    Type: Application
    Filed: December 6, 2018
    Publication date: April 11, 2019
    Applicant: MERCK & CIE
    Inventors: Rudolf MOSER, Viola GROEHN, Thomas EGGER, Thomas AMMANN
  • Patent number: 10059710
    Abstract: The invention is directed towards stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid and its hemisulfate salt as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: August 28, 2018
    Assignee: MERCK & CIE
    Inventors: Rudolf Moser, Viola Groehn, Thomas Egger, Thomas Ammann
  • Publication number: 20180134711
    Abstract: The invention is directed towards stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid and its hemisulfate salt as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.
    Type: Application
    Filed: January 12, 2018
    Publication date: May 17, 2018
    Applicant: MERCK & CIE
    Inventors: Rudolf MOSER, Viola GROEHN, Thomas EGGER, Thomas AMMANN
  • Publication number: 20170233394
    Abstract: The invention is directed towards stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid and its hemisulfate salt as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.
    Type: Application
    Filed: February 17, 2017
    Publication date: August 17, 2017
    Applicant: MERCK & CIE
    Inventors: Rudolf MOSER, Viola GROEHN, Thomas EGGER, Thomas AMMANN
  • Publication number: 20160185787
    Abstract: The present invention is directed towards the hemisulfate salt of 5,10-methylene-(6R)-tetrahydrofolic acid, preferably in substantially crystalline form, as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.
    Type: Application
    Filed: August 14, 2014
    Publication date: June 30, 2016
    Applicant: MERCK & CIE
    Inventors: Rudolf MOSER, Viola GROEHN, Thomas EGGER, Thomas AMMANN
  • Publication number: 20160030573
    Abstract: This invention relates to stable pharmaceutical compositions of 5,10-methylene-(6R)-, -(6S)-, or -(6R,S)-tetrahydrofolate (MTHF), by adjusting a basic pH and the simultaneous use of citrate. Stabilisation is effected even in the absence of a reducing agent. The present invention is particularly suitable for producing lyophlisation solutions and lyophilisates or dry powders and dry mixtures, since the stable MTHF solutions can be used in high concentrations for filling corresponding vessels such as vials, ampoules, etc. The lyophilisates have a surprisingly long shelf life and are surprisingly stable. They can be reconstituted without problems by adding wateror aqueous solutions, and the final clear injection solutions again exhibit excellent stability properties. Moreover, the present invention even makes it possible to prepare difficulty soluble calcium 15 or acidic salts of MTHF in high concentrations and as physiologically compatible isotonic solutions.
    Type: Application
    Filed: October 15, 2015
    Publication date: February 4, 2016
    Applicant: MERCK & CIE
    Inventors: Rudolf MOSER, Thomas AMMANN
  • Patent number: 9180128
    Abstract: This invention relates to stable pharmaceutical compositions of 5,10-methylene-(6R)-, -(65)- or -(6R,S)-tetrahydrofolate (MTHF), by adjusting to a basic pH and the simultaneous use of citrate. Stabilisation is effected even in the absence of a reducing agent. The present invention is particularly suitable for producing lyophilisation solutions and lyophilisates or dry powders and dry mixtures, since the stable MTHF solutions can be used in high concentrations for filling corresponding vessels such as vials, ampoules, etc. The lyophilisates have a surprisingly long shelf life and are surprisingly stable. They can be reconstituted without problems by adding water or aqueous solutions, and the final clear injection solutions again exhibit excellent stability properties. Moreover, the present invention even makes it possible to prepare difficultly soluble calcium 15 or acidic salts of MTHF in high concentrations and as physiologically compatible isotonic solutions.
    Type: Grant
    Filed: June 28, 2004
    Date of Patent: November 10, 2015
    Assignee: MERCK & CIE
    Inventors: Rudolf Moser, Thomas Ammann
  • Publication number: 20150165541
    Abstract: A method and gas mixture of argon, nitrogen and carbon dioxide for tungsten inert gas welding or plasma welding is described wherein the gas mixture is a protective gas for tungsten inert gas welding or an outer gas for plasma welding. The method is particularly useful for welding stainless steels and/or duplex steels.
    Type: Application
    Filed: December 16, 2014
    Publication date: June 18, 2015
    Inventor: Thomas Ammann
  • Publication number: 20130008876
    Abstract: In a Gas Tungsten Arc or Gas Metal Arc welding method for austenitic steel that does not contain Ti or Al in a respective quantity of more than about 0.2% by weight, a welding additive containing Ti and/or Al is used in conjunction with a welding gas that contains nitrogen.
    Type: Application
    Filed: January 11, 2012
    Publication date: January 10, 2013
    Inventor: Thomas Ammann
  • Publication number: 20100025381
    Abstract: A method for arc joining, in particular for M[etal]S[hielding]G[as] welding and/or for M[etal]S[hielding]G[as] soldering of at least one object made of titanium and/or of at least a titanium alloy under shielding gas in the presence of at least one melting electrode, wherein at least an inert gas is supplied as shielding gas in such a manner that the arc burns in a stable and calm manner in response to the arc joining. The shielding gas further includes at least one active gas.
    Type: Application
    Filed: January 21, 2009
    Publication date: February 4, 2010
    Inventor: Thomas AMMANN
  • Patent number: 7612209
    Abstract: Disclosed is a process for the manufacture of pseudo proline dipeptides of the formula wherein R1 is a side chain of an alpha amino acid, R2 is an amino protecting group and R3 and R4 are independently either hydrogen or C1-4-alkyl, and R5 is hydrogen or methyl starting from an amino acid derivative of the formula wherein R1 and R2 are as defined above. Pseudo proline dipeptides can be used as reversible protecting groups for Ser, Thr and Cys and thus are versatile tools in peptide chemistry.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: November 3, 2009
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Thomas Ammann, Stephan Goetzoe, Bernd Thern, Sandra Welz, Klaus-Juergen Wolter
  • Publication number: 20090145884
    Abstract: In order to additionally develop a forming device for delivering at least one root shielding gas to the root side of at least one region to be joined of at least one object, as well as a corresponding method, such that discolorations and the formation of coatings on the object to be joined are effectively prevented, the invention proposes that the delivered root shielding gas is directed, and guided or deflected in the direction along the root side of the region to be joined.
    Type: Application
    Filed: December 3, 2008
    Publication date: June 11, 2009
    Inventors: Thomas AMMANN, Laurentius DRESSEL
  • Publication number: 20090020510
    Abstract: A method for electric arc joining, in particular for arc welding and/or arc soldering, under protective gas using the method of T[ungsten] l[nert] G[as] joining, in particular TIG welding and/or TIG soldering, at least one gas mixture having the composition essentially argon and/or helium and carbon dioxide in a proportion range from approximately 0.2 volume-percent (vol.-%) to approximately 0.7 vol.-% being supplied as the protective gas, as well as a corresponding protective gas, in such a manner that weld pool movements, electric arc turbulence, and occurrences of wear of the T[ungsten] l[nert] G[as] electrode may be reliably avoided. The protective gas also has hydrogen in a proportion range from approximately 1.8 vol.-% to approximately 9 vol.-%.
    Type: Application
    Filed: June 13, 2008
    Publication date: January 22, 2009
    Inventors: Eberhard Brune, Hans Grollimund, Thomas Ammann
  • Patent number: 7388170
    Abstract: This invention provides a method for on-site production of a protective gas mixture for arc joining, in particular for arc welding. Gaseous argon is removed from a liquid argon supply and helium is added to the argon, and a doping gas premix which is prepared separately on-site is added. Various combinations of argon, helium and the doping gas premix are supplied via a protective gas supply device which supplies multiple workplaces with different gas mixtures without the need for specialty gas mixing equipment.
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: June 17, 2008
    Assignee: Linde Aktiengesellschaft
    Inventor: Thomas Ammann